Skip to main content

Perioperative b-adrenergic blocking drugs: from concept to applications

  • Conference paper
Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.
  • 180 Accesses

Abstract

Beta blockers (BB) are selective and competitive antagonists of beta adrenergic receptors. They oppose with their action, to the stimulant effect of the sympathoadrenergic system. Since the differentiation of alpha and beta adrenergic receptors by Alhquist [1], pharmacologists have not ceased to create agonist molecules or increasingly selective antagonists. These molecules are designed to produce the desired action with the least possible secondary effect.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahlquist RP (1948) A study of adrenotropic receptors. Am J Physiol 153: 586–600

    PubMed  CAS  Google Scholar 

  2. Piriou V, Aouifi A, Lehot JJ (2000) Intérêt des bêta-bloquants en médecine périopératoire. Can J Anaesth 7: 653–663

    Google Scholar 

  3. Jones KG, Powell JT (2000) Slowing the heart saves lives: advantages of perioperative ß blockade. Br J Surg 84: 689–690

    Article  Google Scholar 

  4. Roysler RL (2002) Perioperative beta-blockade can reduce morbidity and mortality. APSF Newslett 17: 21–23

    Google Scholar 

  5. Raby KE, Brull SJ, Timimi F et al (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88: 477–482

    PubMed  CAS  Google Scholar 

  6. Coloma M, Chiu JW, White PF, Armbruster SC (2001) The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery. Anesth Analg 92: 352–357

    Article  PubMed  CAS  Google Scholar 

  7. Johansen JW, Schneider G, Windsor AM, Sebel PS (1998) Esmolol potentiates reduction of minimum alveolar isoflurane concentration by alfentanil. Anesth Analg 87: 671–676

    PubMed  CAS  Google Scholar 

  8. Moniotte S, Kobazik L, Feron O et al (2001) Up regulation of b3 adrenoceptors and altered contractility response to inotropic amines in human failing myocardium. Circulation 103: 1649–1655

    PubMed  CAS  Google Scholar 

  9. Zaugg M, Schaub MC, Pasch T, Sphan DR (2002) Modulation of ß adrenergic receptors subtype activities in perioperative medicine: mechanisms and sites of actions. Br J Anaesth 88: 101–123

    Article  PubMed  CAS  Google Scholar 

  10. Gheorghiade M, Colucci S, Swedelberg K (2003) B Blockers in chronic heart failure. Circulation 107: 1570–1575

    Article  PubMed  Google Scholar 

  11. Peterzen B, Lonn U, Babi’c A et al (1999) Anesthetic management of patients undergoing coronary artery bypass grafting with the use of an axial flow pump and a short-acting beta-blocker. J Cardiothorac Vasc Anesth 13: 431–436

    Article  PubMed  CAS  Google Scholar 

  12. Poldermans D, Boeresma E, Bax JJ et al (1999) The effect of bispropolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341: 1789–1794

    Article  PubMed  CAS  Google Scholar 

  13. Auerbach AD, Goldamn L (2002) Beta blockers and reduction of cardiac events in non cardiac surgery. JAMA 287: 1435–1444

    Article  PubMed  CAS  Google Scholar 

  14. Angeja BG, Grossman W (2003) Evaluation and management of diastolic heart failure. Circulation 107: 659–663

    Article  PubMed  Google Scholar 

  15. Vasan RS, Benjamin EJ (2001) Diastolic heart failure — no time to relax. N Engl J Med 1: 56–58

    Article  Google Scholar 

  16. Kim MH, Devlin H, Das SK et al (1999) Effect of ß adrenergic blocking therapy on left ventricular diastolic relaxation proprieties in patients with dilated cardiomiopathy. Circulation 100: 729–735

    PubMed  CAS  Google Scholar 

  17. Nagatsu M, Spinale FG, Koide M et al (2000) Bradycardia and the role of ß blockade in the amelioration of left ventricle dysfunction. Circulation 101: 653–659

    PubMed  CAS  Google Scholar 

  18. Lechat P, Hulot JS, Escolamo S et al (2001) Heart rate and cardiac rhythm relationships with bispropolol benefit in chronic heart failure in CIBIS II trial. Circulation 103: 1428–1433

    PubMed  CAS  Google Scholar 

  19. Landesburg G, Zhou W, Aversano T (1999) Tachycardia—induced subendocardial necrosis in acutely instrumented dogs with fixed coronary stenosis. Anesth Analg 88: 973–979

    PubMed  CAS  Google Scholar 

  20. Pasternack PF, Imparato AM, Bauman FG et al (1987) The hemodynamics of beta blockade in patient undergoing abdominal aortic aneurysm repair. Circulation 76 (Suppl III): 1–7

    Google Scholar 

  21. Fita G, Gomar C, Rovira I (1999) Esmolol en anestesiologfa: farmacologfa e indicaciones. Rev Esp Anestesiol Reanim 46: 404–414

    PubMed  CAS  Google Scholar 

  22. Grossman W (2000) Defining diastolic dysfunction. Circulation 101: 2020–2021

    PubMed  CAS  Google Scholar 

  23. Banerjee P, Banerjee T, Khand A et al (2002) Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 39: 138–141

    Article  PubMed  Google Scholar 

  24. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: part I. Circulation 105: 1387–1393

    Article  PubMed  Google Scholar 

  25. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: part II. Circulation 105: 1503–1508

    Article  PubMed  Google Scholar 

  26. Bristow MR (1997) Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 80: 26L - 40L

    Article  PubMed  CAS  Google Scholar 

  27. Krum H (1999) ß blockers in heart failure. The “new wave” of clinical trials. Drugs 58: 203–210

    Article  PubMed  CAS  Google Scholar 

  28. Muchada R (2002) Cardio beta modulation with dobutamine — esmolol simultaneous perfusion. Anesthesiology 96: A635

    Google Scholar 

  29. Muchada R (1999) Non invasive hemodynamic diagnostic of hyperkinetic septic shock treated with 13 blocker. Intensive Care Med 25 Suppl 1: 142

    Google Scholar 

  30. Shakar SF, Abrham WT, Gilbert EM et al (1998) Combined oral positive inotropic and 13 blockers therapy for treatment of refractory class VI heart failure. J Am Coll Cardiol 31: 1336–1340

    Article  PubMed  CAS  Google Scholar 

  31. Bristow MR, Shakar SF, Linseman JV et al (2001) Inotropes and 13—blockers: is there a need for new guidelines? J Cardiac Failure 72 (Suppl 1): 8–12

    Article  Google Scholar 

  32. Bristow M (2003) Antiadrenergic therapy of chronic heart failure. Surprises and new opportunities. Circulation 107: 1100–1102

    Article  PubMed  Google Scholar 

  33. Magnano DT, Layug EL, Wallace A et al (1996) Effect of atenolol on mortality and morbidity after non cardiac surgery. Multicenter study of perioperative research group. N Engl J Med 335: 1713–1720

    Article  Google Scholar 

  34. Harwood TN, Butterworth J, Prielipp RC et al (1999) The safety and the effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth 13: 555–561

    Article  PubMed  CAS  Google Scholar 

  35. Frishman WH, Cheng A (1999) Secondary prevention of myocardial infarction: role of beta adrenergic blockers and angiotensin converting enzyme inhibitors. Am Heart J 137: S25 - S34

    Article  PubMed  CAS  Google Scholar 

  36. Palatini P, Casaglia E, Julius S, Pessina AC (1999) High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 159: 585–592

    Article  PubMed  CAS  Google Scholar 

  37. Barbier GH, Shettigar UR, Appunn DO (1995) Clinical rationale for the use of an ultra short acting beta-blocker; esmolol. Int J Clin Pharmacol Ther 33: 212–218

    PubMed  CAS  Google Scholar 

  38. Leug JM, Manku K (2000) Prophylactic therapy of preoperative myocardial ischemia. Curr Anesthesiol Rep 2: 77–85

    Google Scholar 

  39. Howell SJ, Sear JW, Foex P (2001) Peri-operative 13-blockade a useful treatment that should be greeted with cautious enthusiasm. Br J Anaesth 2: 161–164

    Article  Google Scholar 

  40. Kleiman B (2002) Perioperative beta-blockade requires further study — not standard of care. APSF Newslett 17: 55

    Google Scholar 

  41. Manigaux C, Guignard B, Adam F et al (2002) Esmolol prevent movement and attenuates BIS response to orotracheal intubation. Br J Anaesth 89: 857–862

    Article  Google Scholar 

  42. Than PH, Yang LC, Shih HC et al (2002) Combined use of esmolol and nicardipine to blunt the haemodynamic changes following laryngoscopy and tracheal intubation. Anaesthesia 57: 1195–1212

    Article  Google Scholar 

  43. Scott DB, Buckley FP, Drumond GB et al (1978) Cardiovascular effect of labetalol during halothane anaesthesia. Br J Anaesth 3 (Suppl): 817–821

    Google Scholar 

  44. Edmonson R, Del Valle O, Sha N et al (1989) Esmolol for potation of nitroprusside-induced hypotension: impact on the cardiovascular adrenergic and rening angiotensin systems in men. Anesth Analg 69: 202–206

    Google Scholar 

  45. Gold MI, Sacks DJ, Grosnoff DB et al (1989) Use of esmolol during anesthesia to treat tachycardia and hypertension. Anesth Analg 68: 104–104

    Article  Google Scholar 

  46. Seltzer JL, Ritter DE, Starsnic MA, Man AT (1985) The hemodynamic response to traction on the abdominal mesentery. Anesthesiology 63: 96–99

    Article  PubMed  CAS  Google Scholar 

  47. Muchada R (2001) Mesure du débit aortique par méthode non invasive. In: Dalens B (ed) Traité d’anesthésie générale, vol 4. Arnette, Rueil-Malmaison, pp 2–18

    Google Scholar 

  48. Peterson GE, Brickner E, Reimold SC (2003) Transesophageal echocardiography. Clinical indications and applications. Circulation 107: 2398–2402

    Article  PubMed  Google Scholar 

  49. Askenazi J, MacCosbe PE, Hoff J et al (1987) Hemodynamic effects of esmolol, an ultrashortacting beta blocker. J Clin Pharmacol 27: 567–573

    PubMed  CAS  Google Scholar 

  50. Buffington CW (1985) Hemodynamic determinants of ischemia myocardial disfunction. Aneshtesiology 63: 655–662

    Google Scholar 

  51. Menkaus PG, Reyes JG, Kissing Yet al (1985) Cardiovascular effects of esmolol in anesthetized humans. Anesth Analg 64: 327–334

    Google Scholar 

  52. Reilly CS, Wood M, Kosakii RP, Wood AJ (1985) Ultra-short-acting-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther 38: 579–585

    Article  PubMed  CAS  Google Scholar 

  53. Sasao J, Tarver SD, Kindscher JM et al (2001) In rabbits, landiolol, a new ultra-short-acting ß-blocker exert more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 48: 985–989

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Muchada, R. (2004). Perioperative b-adrenergic blocking drugs: from concept to applications. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2189-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2189-1_7

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0235-7

  • Online ISBN: 978-88-470-2189-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics